Bayer gets European Approval for its Novel Anticoagulant

Bayer's novel anticoagulant Xarelto has been granted marketing authorization in Europe. by Pierre-Philippe Luyet, PhD , 03/10/2008

FDA approval for The Medicines Company's drug

The Medicines Company introduces its second drug to the market. by Pierre-Philippe Luyet, PhD , 07/08/2008

InnerCool's CoolBlue Enters the European Therapeutic Hypothermia Market

InnerCool's temperature modulation business sold in collaboration with existing specialized sales organizations.03/04/2008

UCB Shares Drop dramatically After Announce on Neupro Recall

03/04/2008